Geisinger Announces New National Precision Health Initiative | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Geisinger Announces New National Precision Health Initiative

November 16, 2017
by Heather Landi
| Reprints

Danville, Pa.-based Geisinger Health System has launched a new National Precision Health Initiative, an effort to extend the Geisinger model of integrating genomics and data science into precision healthcare on the national scene.

The new Geisinger National Precision Health Initiative, based in the Washington, D.C., area, will provide increased national exposure for the Geisinger model, as well as for launching new strategic partnerships and ventures. 

The program will leverage Geisinger’s MyCode Community Health Initiative and electronic health data integration. Geisinger already has more than 160,000 participants enrolled in its MyCode Community Health Initiative, a precision medicine project that includes a system-wide biobank designed to store blood and other samples used by researchers to help develop optimal treatments tailored to the individual needs of Geisinger patients. The MyCode Community Health Initiative launched in January 2014 in collaboration with the Regeneron Genetics Center.

The health system also announced the appointment of Huntington F. Willard, Ph.D., as its first director. Willard is a former president of the American Society of Human Genetics, founding director of the Duke Institute for Genome Sciences & Policy, and the 15th President of the Marine Biological Laboratory.  In addition to an extensive list of over 300 research publications, Willard is co-editor of the first textbook on precision medicine titled "Genomic & Precision Medicine.”

To accelerate innovation in the Geisinger National Precision Health Initiative, Willard will launch a new Precision Health Innovation Lab, leveraging discoveries and advances in genomics and data science throughout Geisinger.

"I'm thrilled to be joining the Geisinger family. I know of no other health system with such dedication to putting patients and their health first," Willard said in a statement. "I look forward to launching new programs committed to broadening Geisinger's impact in precision health on a national scale."

David H. Ledbetter, Ph.D., Geisinger executive vice president and chief scientific officer, said in a statement that Hunt Willard has built world-class genomics and precision health programs at several academic institutions and his leadership will greatly enhance Geisinger’s ability to rapidly expand the Geisinger model for precision health on a national scale.

David T. Feinberg, M.D., Geisinger president & CEO, said in a statement, “The addition of Hunt Willard to our already outstanding genomics and precision health team at Geisinger allows us to 'double-down' on our bet on this game-changing approach to anticipatory medicine – preventing early-onset cancer, cardiovascular events, and other diseases, and keeping people out of hospitals. We are already seeing this benefit to our patients in Pennsylvania and New Jersey and are eager to extend this program nationally.”

An elected member of both the National Academy of Sciences and the National Academy of Medicine, Willard will be professor of precision health and associate chief scientific officer at Geisinger, as well as director of the Geisinger National Precision Health Initiative.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

ONC Roundup: Senior Leadership Changes Spark Questions

The Office of the National Coordinator for Health IT (ONC) has continued to experience changes within its upper leadership, leading some folks to again ponder what the health IT agency’s role will be moving forward.

Media Report: Walmart Hires Former Humana Executive to Run Health Unit

Reigniting speculation that Walmart and insurer Humana are exploring ways to forge a closer partnership, Walmart Inc. has hired a Humana veteran to run its health care business, according to a report from Bloomberg.

Value-Based Care Shift Has Halted, Study Finds

A new study of 451 physicians and health plan executives suggests that progress toward value-based care has stalled. In fact, it may have even taken a step backward over the past year, the research revealed.

Study: EHRs Tied with Lower Hospital Mortality, But Only After Systems Have Matured

Over the past decade, there has been significant national investment in electronic health record (EHR) systems at U.S. hospitals, which was expected to result in improved quality and efficiency of care. However, evidence linking EHR adoption to better care is mixed, according to medical researchers.

Nursing Notes Can Help Predict ICU Survival, Study Finds

Researchers at the University of Waterloo in Ontario have found that sentiments in healthcare providers’ nursing notes can be good indicators of whether intensive care unit (ICU) patients will survive.

Health Catalyst Completes Acquisition of HIE Technology Company Medicity

Salt Lake City-based Health Catalyst, a data analytics company, has completed its acquisition of Medicity, a developer of health information exchange (HIE) technology, and the deal adds data exchange capabilities to Health Catalyst’s data, analytics and decision support solutions.